These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 390116)
1. Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect. Dickinson RG; Harland RC; Ilias AM; Rodgers RM; Kaufman SN; Lynn RK; Gerber N J Pharmacol Exp Ther; 1979 Dec; 211(3):583-95. PubMed ID: 390116 [TBL] [Abstract][Full Text] [Related]
2. Nonlinear elimination and cholerteic effect of valproic acid in the monkey. Dickinson RG; Taylor SM; Kaufman SN; Rodgers RM; Lynn RK; Gerber N; Baughman WL J Pharmacol Exp Ther; 1980 Apr; 213(1):38-48. PubMed ID: 6767022 [TBL] [Abstract][Full Text] [Related]
3. Impaired biliary elimination of beta-glucuronidase-resistant "glucuronides" of valproic acid after intravenous administration in the rat. Evidence for oxidative metabolism of the resistant isomers. Dickinson RG; Kluck RM; Wood BT; Eadie MJ; Hooper WD Drug Metab Dispos; 1986; 14(2):255-62. PubMed ID: 2870903 [TBL] [Abstract][Full Text] [Related]
4. Disposition of beta-glucuronidase-resistant "glucuronides" of valproic acid after intrabiliary administration in the rat: intact absorption, fecal excretion and intestinal hydrolysis. Dickinson RG; Kluck RM; Eadie MJ; Hooper WD J Pharmacol Exp Ther; 1985 Apr; 233(1):214-21. PubMed ID: 3920383 [TBL] [Abstract][Full Text] [Related]
5. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat. Watkins JB; Klaassen CD J Pharmacol Exp Ther; 1982 Feb; 220(2):305-10. PubMed ID: 6799642 [TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
7. pH-dependent rearrangement of the biosynthetic ester glucuronide of valproic acid to beta-glucuronidase-resistant forms. Dickinson RG; Hooper WD; Eadie MJ Drug Metab Dispos; 1984; 12(2):247-52. PubMed ID: 6144492 [TBL] [Abstract][Full Text] [Related]
8. Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats. Yamamura N; Imura K; Naganuma H; Nishimura K Drug Metab Dispos; 1999 Jun; 27(6):724-30. PubMed ID: 10348803 [TBL] [Abstract][Full Text] [Related]
9. An osmotic explanation for valproic acid induced choleresis in the rat, dog and monkey. Dickinson RG; Harland RC; Kaufman SN; Lynn RK; Gerber N Arzneimittelforschung; 1982; 32(3):241-7. PubMed ID: 6805484 [TBL] [Abstract][Full Text] [Related]
10. Materno-fetal pharmacokinetics and fetal distribution of valproic acid in a pregnant rhesus monkey. Dickinson RG; Lawyer CH; Kaufman SN; Lynn RK; Gerber N; Novy MJ; Cook MJ Pediatr Pharmacol (New York); 1980; 1(1):71-83. PubMed ID: 6810290 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat. Liu MJ; Brouwer KL; Pollack GM Drug Metab Dispos; 1992; 20(6):810-5. PubMed ID: 1362931 [TBL] [Abstract][Full Text] [Related]
12. Chemical and immunochemical comparison of protein adduct formation of four carboxylate drugs in rat liver and plasma. Bailey MJ; Dickinson RG Chem Res Toxicol; 1996; 9(3):659-66. PubMed ID: 8728513 [TBL] [Abstract][Full Text] [Related]
13. Disposition and protein binding of valproic acid in the developing rat. Haberer LJ; Pollack GM Drug Metab Dispos; 1994; 22(1):113-9. PubMed ID: 8149869 [TBL] [Abstract][Full Text] [Related]
14. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
15. Application of the two-compartment open model with Michaelis-Menten elimination kinetics to valproic acid in the bile-exteriorized rat. Lawyer CH; Gerber N; Lynn RK; Dickinson RG Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):469-84. PubMed ID: 6770426 [TBL] [Abstract][Full Text] [Related]
16. Site-dependent intestinal hydrolysis of valproate and morphine glucuronide in the developing rat. Pollack GM; Spencer AP; Horton TL; Brouwer KL Drug Metab Dispos; 1994; 22(1):120-3. PubMed ID: 8149870 [TBL] [Abstract][Full Text] [Related]
17. The early effects of valproic acid in low doses in liver metabolism. Culebras M; Doval M; Rengel M; López-Novoa JM Rev Esp Fisiol; 1989 Dec; 45(4):327-30. PubMed ID: 2517150 [TBL] [Abstract][Full Text] [Related]
18. Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid. Korkmazer N; Vurucu S; Demirkaya E; Unay B; Kul M; Akin R; Gokcay E Brain Dev; 2006 Sep; 28(8):515-20. PubMed ID: 16682156 [TBL] [Abstract][Full Text] [Related]
19. Abolition of valproate-derived choleresis in the Mrp2 transporter-deficient rat. Wright AW; Dickinson RG J Pharmacol Exp Ther; 2004 Aug; 310(2):584-8. PubMed ID: 15075379 [TBL] [Abstract][Full Text] [Related]
20. Metabolism and choleretic effect of naltrexone in the isolated perfused rat liver. Rodgers RM; Taylor SM; Dickinson RG; Ilias AM; Lynn RK; Gerber N Drug Metab Dispos; 1980; 8(6):390-6. PubMed ID: 6109606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]